Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186704 · ClinicalTrials.gov registry record
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
A clinical trial of Atrial Fibrillation, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 450
- Enrollment target
- 8
- Study locations
NCT02186704: Completed study of Atrial Fibrillation, sponsored by Weill Medical College of Cornell University.
NCT02186704 is a study of Atrial Fibrillation that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 450 participants, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (85% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02186704, a study of Atrial Fibrillation, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
- 8
- Study locations
Study Summary
The primary aim of the "Sensing Atrial High Rate Episodes with DX System in Implantable Cardioverter Defibrillators Trial" (SENSE Trial) is to assess the efficacy of a implantable cardioverter-defibrillator (ICD) lead with dedicated atrial sensing dipoles in detecting atrial high rate episodes. The study hypothesis is that an ICD system with a lead with dedicated atrial sensing dipoles will have a diagnostic yield comparable to that of a standard dual chamber ICD system and superior to that of a standard single chamber ICD system.
Primary Outcome
Atrial high rate episode \> 30 seconds in duration
Conditions Studied
Interventions
- DEVICE ICD with DX system
Study Locations (8)
New York
- Weill Cornell Medical College - New York
- Westchester Medical Center - Valhalla
Ohio
- The Ohio State Wexner University Medical Center - Columbus
- Promedica Heart and Vascular Institute - Toledo
Alabama
- University of Alabama at Birmingham - Birmingham
Massachusetts
- Massachusetts General Hospital - Boston
Pennsylvania
- Einstein Medical Center - Philadelphia
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-07 |
What the finished NCT02186704 record still lists
NCT02186704 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which ICD with DX system is the first listed.
NCT02186704 lists 8 locations in 6 states (New York, Ohio, Alabama).
Frequently Asked Questions
What is clinical trial NCT02186704 about?
NCT02186704 is a clinical study titled "Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)". The primary aim of the "Sensing Atrial High Rate Episodes with DX System in Implantable Cardioverter Defibrillators Trial" (SENSE Trial) is to assess the efficacy of a implantable cardioverter-defibrillator (ICD) lead with dedicated atrial sensing dipoles in detecting atrial high rate episodes. The...
What is the current status of trial NCT02186704?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2014-07. Estimated completion is 2018-07.
What conditions does trial NCT02186704 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT02186704?
The interventions under investigation include: ICD with DX system (DEVICE).
Who is sponsoring clinical trial NCT02186704?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02186704 being conducted?
This trial has 8 study locations across Alabama, Massachusetts, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02186704's enrollment target sits among peer trials
450 63rd of 202 higher than 140 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia